Chapter 22. Lung Cancer in the Elderly
- Stephen Jackson Professor of Geriatric Medicine2,
- Paul Jansen3,
- Arduino Mangoni4
Published Online: 2 APR 2009
DOI: 10.1002/9780470017975.ch22
Copyright © 2009 John Wiley & Sons, Ltd
Book Title

Prescribing for Elderly Patients
Additional Information
How to Cite
Bowden, J. (2009) Lung Cancer in the Elderly, in Prescribing for Elderly Patients (eds S. Jackson, P. Jansen and A. Mangoni), John Wiley & Sons, Ltd, Chichester, UK. doi: 10.1002/9780470017975.ch22
Editor Information
- 2
Department of Clinical Gerontology, King's College Hospital, London, UK
- 3
Department of Geriatric Medicine, University Medical Centre Utrecht, Utrecht, The Netherlands
- 4
Department of Clinical Pharmacology, Flinders University, Flinders Medical Centre, Adelaide, Australia
Publication History
- Published Online: 2 APR 2009
- Published Print: 27 MAY 2009
ISBN Information
Print ISBN: 9780470024287
Online ISBN: 9780470017975
- Summary
- Chapter
Keywords:
- lung cancer in elderly;
- chemotherapeutic agents;
- ECOg performance status*;
- treatment protocols for NSCLC;
- surgical resection as primary treatment for stage 1 carcinoma;
- vinca alkaloids (vincristine, vindesine, vinblastine, vinorelbine);
- chemotherapy for combined therapy for stage 3A and 3B disease;
- 1st line therapy for advanced disease - combination therapy;
- non cytotoxic agents - EGFR inhibitors
Summary
This chapter contains sections titled:
Introduction
Aetiology
Symptoms and signs
Diagnosis and staging
Goals of therapy
Chemotherapeutic agents
Treatment protocols for NSCLC
Non cytotoxic agents: EGFR Inhibitors
Treatment of small cell carcinoma
Treatment of mesothelioma
Anti-emetic therapy
Key Points
Guidelines
References
